YAP1 and neoplasm: Conclusively, our results show that DEX treatment elevated ROR1 expression, which in turn enhanced RhoA, YAP/TAZ, and BMI-1 levels in OC tumor cells and is indicative of a DEX-mediated stemness phenotype via ROR1 signaling.